Targeting Microbiota 2024: Confirmed Speakers

Gut Microbiome, Obesity and Diabetes
Hiroshi Ohno, RIKEN Center for Integrative Medical Sciences, Japan

Targeting Gut and Skin by Phages: Towards the Next Clinical Revolution
Mzia Kutateladze, Eliava Institute of Bacteriophage, Georgia

Mythbusting Our Microbiome
Alan Walker, Professor (Personal Chair), University of Aberdeen, United Kingdom

Probiotics & Health: How to Select the Right Strain?
Andreas Schwiertz, Institute of Microecology, Germany

Gut Brain Axis & Depression: Startegic Role of Dietary Proline Exposed
José Manuel Fernández-Real, Institut d'Investigació Biomèdica de Girona, Hospital Trueta de Girona, CIBERobn and University of Girona, Spain

Targeting Small Intestinal Microbiota: Impact on Metabolism
Pascale Vonaesch, Lausanne University, Switzerland

Microbiota-Derived Extracellular Vesicles: Bridging Mother and Fetus
Justus Reunanen, University of Oulu, Finland

Microbial Phenotypes in Obesity: Implications for Precision Nutrition
Ellen Blaak, Maastricht University, Netherlands

Bacteriophages Redesigned – Tiny Killers and Detectives to Support Infectious Disease Therapy
Martin Loessner, ETH Zurich, Switzerland

Sophisticated in vitro Models of the Gastrointestinal Tract to Study the Role of the Gut Microbiota in Health and Disease
Koen Venema, Editor-in-chief of Beneficial Microbes, Netherlands

Gut Microbiota in Early Life: Impact on Neurodevelopmental Outcomes
Rochellys Diaz Heijtz, Karolinska Institutet, Sweden

Gut Bacteria and Heart Healing: The Hidden Players in Post-Infarction Resilience
Patrick C. H. Hsieh, Academia Sinica, Tawian

The Oral-Placental Microbiome Axis in Preterm Birth
Souhaila Al Khodor, Sidra Medicine, Qatar

Gut Microbiome Signatures in Irritable Bowel Syndrome
Simone Domenico Guglielmetti, Università degli Studi di Milano-Bicocca, Italy

From Microbiomes and (Meta)genomes to the Lab and Back - Identification, Production and Application of Bacteriocins
Christian Riedel, University of Ulm, Germany